IGFBP3 and colorectal carcinoma: Here, this study records the downregulation of serum IGF1 and upregulation of its major binding protein IGFBP3 in CRC patients and this dysregulation was similarly reflected in the sera of obese CRC patients compared to their corresponding non-obese patients.